AURO LABORATORIES LTD.

NSE : NABSE : 530233ISIN CODE : INE292C01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE232.105.3 (+2.34 %)
PREV CLOSE ( ) 226.80
OPEN PRICE ( ) 233.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1689
TODAY'S LOW / HIGH ( )227.00 238.10
52 WK LOW / HIGH ( ) 75.12307.2
NSE
This Company is not listed in NSE
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1989
Management Info
Sharat Deorah - Chairman Sharat Deorah - Managing Director
Registered Office

Address K 56 M I D C Industrial Area,Boisar,Tarapur,
Palghar,
Maharashtra-401506

Phone 022- 56635456

Email auro@aurolabs.com

Website www.aurolabs.com

Registrars Details
Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE
NEWS
07May Clarification On Price Movement
We are submitting herewith our reply to BSE''s email dated May 3, 2024 s..
07May Clarification sought from Auro Labora
The Exchange has sought clarification from Auro Laboratories Ltd on May..
22Mar Auro Laboratories informs about disclo
Auro Laboratories has informed about disclosure under Regulation 29(2) o..
06Mar Auro Laboratories informs about loss o
Auro Laboratories has informed that share certificates have been reporte..
25Jan Auro Laboratories inks pact with MIDC
Auro Laboratories has entered into an Agreement with Maharashtra Industr..
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit27.3424.41
Gross Profit 37.88 34.45
Operating Profit 45.0353.33
Net Sales 179.78528.94
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 26643.70 (0.58%)
M.Cap (Rs. in Cr)56616.00
Pfizer (BSE)
 4473.85 (1.59%)
M.Cap (Rs. in Cr)20466.85
Glaxosmithkline Phar (BSE)
 2355.75 (2.80%)
M.Cap (Rs. in Cr)39907.83
Concord Biotech (BSE)
 1494.85 (4.43%)
M.Cap (Rs. in Cr)15638.55
Zydus Lifesciences (BSE)
 1104.45 (5.00%)
M.Cap (Rs. in Cr)111133.51
Shareholding Pattern
PROMOTERS 52.15%
NON-INSTITUTION 47.84%
MUTUAL FUNDS/UTI 0.01%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
No Data Found
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances

Notices/Communique Links

INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.